Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Steven C. Quay currently holds 88,038 shares of NASTECH PHARMACEUTICAL CO INC (NSTK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Steven C. Quay has been a net seller of NSTK stock. They have purchased $23.5K and sold $981.0K worth of shares.
Steven C. Quay's most recent insider trade was on Mar 27, 2026, when they sold 65,000 shares at $0.00 per share.
Steven C. Quay serves as Executive at NASTECH PHARMACEUTICAL CO INC (NSTK). They have executed 59 insider transactions totaling $1.0M over their tenure at the company.
Steven C. Quay holds the position of Executive at NASTECH PHARMACEUTICAL CO INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Steven C. Quay has shown a selling trading pattern, with $23.5K in total purchases and $981.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Steven C. Quay was on Jan 20, 2026, when they purchased $572.9K worth of ATOS shares. This transaction involved 950,000 shares at $0.60 per share.
Steven C. Quay currently owns 88,038 shares of NASTECH PHARMACEUTICAL CO INC (NSTK), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Steven C. Quay's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Steven C. Quay has 59 Form 4 filings on record as an insider at NASTECH PHARMACEUTICAL CO INC.
Set alerts for Steven C. Quay and 40,000+ other insiders.